HLA mismatching, and acute rejection episodes [2] [3] [4] . Renal function within the first year of transplantation year and delta creatinine (change in serum creatinine between also has been reported to an important factor influencing 6 months and 1 year). Graft half-life was used to measure longgraft survival [4] [5] [6] [7] [8] . Previous studies that examined renal term survival.
function have either been from a single center in the conResults. During this 11-year period, the one-year serum creatinine values for cadaver recipients steadily improved, from text of acute rejection episode or have utilized discharge 1.82 Ϯ 0.82 mg/dL in 1988 to 1.67 Ϯ 0.82 mg/dL in 1998 (P Ͻ creatinine values [4] [5] [6] [7] [8] . Therefore, it has not been possi-0.001), as did the graft half-life. There was a progressive decline ble to separate the effects of renal function and other in graft half-life for each incremental increase of six month, confounding variables such as acute rejection and DGF. one year and ⌬ creatinine for living and cadaver donor transplants as well for cadaver transplants with donor age Ͼ and The purpose of this study was to examine renal func-Յ50 years. The Relative Hazard (RH) for graft failure was tion in the first year of transplantation as an independent 1.63 (1.61, 1.65; P Ͻ 0.0001) with each increment of 1.0 mg/dL variable in determining long-term renal graft survival.
of serum creatinine at one year post-transplant and it increased to 2.26 (2.2, 2.31; P Ͻ 0.0001) when the ⌬ creatinine was Our hypothesis was that preservation of renal function 0.5 mg/dL. The RH reduction for graft failure was substantially in the first year might provide additional explanation for lower for the years 1993, 1996, 1997 and 1998 when postimprovements in graft half-life that have been noted retransplant renal function was not included in the model (P Ͻ cently. To accomplish this we reviewed 105,742 adult 0.05). However, the RH reduction per year was not different when post-transplant creatinine was included in the model, renal transplants in the United States performed be-1.01 (0.94 to 1.05; P ϭ 0.89).
tween 1988 and 1998.
Conclusion.
In conclusion, one-year creatinine and ⌬ creatinine values predict long-term renal graft survival. Recent improvements in graft half-life are related to conservation of These data were analyzed according to the methodology defined in this section. Patients who had multiorgan transplants such as kidney/pancreas and pediatric recipients (age Ͻ18 years) were excluded. These patients were followed until November 2000.
Post-transplant renal function considered in this study was defined as: serum creatinine at six months and one year and ⌬ creatinine (the change in creatinine from 6 months to 1 year). Patients were stratified into six groups according to their six month and one year posttransplant serum creatinine values: Ͻ1.0, 1-1.5, 1.6-2.0, 2.1-2.5, 2.6-3.0 and Ͼ3.0 mg/dL. They were also divided into seven groups, according to their ⌬ creatinine value: Ͻ0.1, 0.1-0.2, 0.3-0.4, 0.5-0.9, 1.0-1.9, 2.0-2.9, and Ն3.0 gan source: living and cadaver donor transplants, and cadaver donor transplants according to donor age Յ and Ͼ50 years. The Kaplan-Meier method was used to esti-RESULTS mate graft survival [9] . A maximum likelihood estimate of the projected half-life (median value) was calculated A total of 105,742 adult renal transplants (77,582 caassuming exponentially distributed graft survival times.
daver and 28,160 living donor transplants) performed in Additional analyses were performed after censoring pathe United States between 1988 and 1998 were included tients who died while their grafts were functioning. in this study. Of these, 18,589 cadaver transplants were The demographic variables used for covariate-adjusted performed using kidneys from donors Ͼ50 years. The oneanalyses included age, sex, and race of the recipient and year graft survival rate for living donor transplants in the donor. Other recipient variables included prior trans-1988 was 89.7%. This improved to 94.3% in 1998, an inplantation, pre-transplant blood transfusions, titer of secrement of 4.6 percentage points. During the same period rum panel reactive antibody (PRA) in the recipient, graft survival rates for cadaver donor transplants imwhether or not the patient received maintenance dialysis proved from 76.0% to 89.3%, an increase of 13.3 percentprior to transplant and associated medical conditions age points. Figure 1 shows the Kaplan-Meier estimates such as diabetes as the cause for end-stage renal failure of survival of renal grafts for cadaver transplant for each (ESRF). Transplant variables included the source of oryear from 1988 to 1998. The cohorts of patients transgan (living or cadaveric donor), duration of cold ischemia planted in recent years have better short and long-term time, extent of HLA mismatching, presence or absence survival rates than patients transplanted in early years. of delayed graft function (DGF; defined as post-trans- Figure 2 shows the Kaplan-Meier estimates for caplant dialysis within one week after transplant) and year daver grafts survival according to six month creatinine in which transplant was performed. Post-transplant vari-( Fig. 2A ), one year creatinine (Fig. 2B ) and ⌬ creatinine ables included use of antibody induction, discharge main- (Fig. 2C) values. Post-transplant creatinine Ͼ1.5 mg/dL tenance immunosuppression with mycophenolate moat six months and one year, and ⌬ creatinine Ն0.3 mg/dL fetil or tacrolimus, clinical acute rejection within one year were associated with a decline in long-term graft survival. and post-transplant renal function as previously defined.
Similar survival patterns were noted for living donor The analyses were performed with and without postgrafts as well for cadaver donor grafts from donors Յ transplant renal function to assess whether transplant and Ͼ50 years of age (not shown). Table 1 shows the year and post-transplant renal function are surrogates graft half-life for various post-transplant renal function for each other.
groups, with and without censoring for death with a The multivariate analyses were performed using profunctioning graft. These are stratified according to organ portional hazards regression models adjusted for all varisource (living and cadaver donor transplants) as well as ables listed above. The relative hazard (RH) for longcadaver donor age (donor age Յ and Ͼ50 years). A term graft failure conditioned on survival to one year decline in graft half-life was noted with progressive inand corresponding 95% confidence intervals (CI) were creases in six month and one year creatinine values as estimated. Reporting bias associated with rapid notificawell as with increasing ⌬ creatinine values. tion of critical events (graft failure, death) and delayed
The mean creatinine (ϮSD) values at six months and notification for continued survival was not accounted for one year declined over time. For example, mean creatinine at one year decreased for living donor transplants in this analysis. There were differences in demographic and post-transplant variables for cadaveric recipients with one year in 1998 (P Ͻ 0.001). During the same period similar changes in renal function were noted for cadaver transcreatinine Յ and Ͼ1.5 mg/dL as shown in Table 2 . Those with elevated creatinine at one year (serum creatinine plants: 1.82 Ϯ 0.82 to 1.67 Ϯ 0.82 mg/dL (P Ͻ 0.001), cadaver donor transplants with donor age Յ50 years Ͼ1.5 mg/dL) were more likely to be male, black and have had a previous transplant. They were less likely 1.76 Ϯ 0.79 to 1.58 Ϯ 0.77 mg/dL (P Ͻ 0.001), and donor age Ͼ50 years 2.34 Ϯ 0.93 to 1.99 Ϯ 0.87 mg/dL (P Ͻ to have the diagnosis of diabetes than recipients with creatinine Յ1.5 mg/dL at one year. Donor factors were 0.001). Figure 3 shows the cumulative distribution of one-year serum creatinine values for cadaveric recipients also different: those with elevated creatinine levels were more likely have been recipients of a kidney from a for 1988 and 1997. The distribution of serum creatinine was much lower in the cohort of patients transplanted female donor, black donor, or an older donor. Recipients with creatinine Ͼ1.5 mg/dL at one year were also more in 1997. Similar trends were observed for serum creatinine at six months post-transplant and in ⌬ creatinine likely to have cold ischemia time Ͼ24 hours, DGF, clinical acute rejection within one year, and less likely to have (data not shown) values. Figure 4 shows the projected median graft half-life for received a zero-mismatched kidney. Similar differences were noted in patients who had living donor transplant each year for all cadaver transplants and for cadaver transplants according to one year creatinine values (Յ (data not shown). Thus, demographic variables such as donor/recipient age, sex, and race and transplant variand Ͼ1.5 mg/dL). Overall improvement in half-life was seen for cadaver transplants from 7.9 (7.6, 8.2) in 1988 ables such as cold ischemia time, DGF and acute rejection are key factors contributing to elevated creatinine to 11.2 (10.1, 12.2) years in 1997, an increase of 42%. During the same period, the improvements in half-life after transplantation. Figure 5 shows the graft half-life for cadaver recipients in cadaver transplants with creatinine Ͼ1.5 mg/dL was 6.2 (5.9, 6.5) to 7.5 (6.7, 8.4) years, an increase of 21%, according to the combination of one year creatinine (Յ and Ͼ1.5 mg/dL) and ⌬ creatinine (Ͻ and Ն0.3 mg/dL) and for one year creatinine Յ1.5 mg/dL, was from 10.9 (10.2, 11.7) to 19 (15.9, 22.1) years, an increase of 74%. along with the presence or absence of prior clinical acute rejection. Recipients with creatinine Ͼ1.5 mg/dL with ⌬ Similarly, older donor age and black donor race increased the risk of long-term failure. Living donor transcreatinine Ն0.3 mg/dL have a substantially lower projected graft half-life than all other groups regardless of plant recipients had a decreased risk of graft failure. Transplant variables such as increasing HLA mismatch prior acute rejection. Rejection episodes had greatest impact for recipients with serum creatinine Յ1.5 and ⌬ level and DGF also were associated with increased risk of graft failure. creatinine Ն0.3 mg/dL.
The results of the proportional hazard analysis are There was also a significant interaction between the different measures of post-transplant renal function as shown shown in Table 3 . The parameter estimate, RH, 95% CI, and P value are shown for each recipient, donor, transin Figure 6 . Serum creatinine increment of 1.0 mg/dL, at one year post-transplant without a change in ⌬ creatiplant, and post-transplant characteristic included in the final model. Some significant factors that increased the nine, increased RH of graft failure to 1.63 (1.61, 1.65; P Ͻ 0.0001). However, when this was accompanied with risk of graft failure include recipient variables such as older age, black race, diabetes, and previous transplant. a change in ⌬ creatinine of 0.5 and 1.0 mg/dL, the RH are in part due to better preservation of renal function within the first year.
In the current analysis, a progressive decline in graft survival rates was noted for all groups, with and without of graft failure increased to 2.26 (2.2, 2.31) and 3.13 (2.99, censoring for death with a functioning graft, when the 3.27; P Ͻ 0.0001), respectively. Thus, increases in both one year creatinine value was Ͼ1.5 mg/dL or ⌬ creatinine the serum creatinine value at one year and in the ⌬ crewas Ն0.3 (Table 1 ). The improved half-life in recent years atinine resulted in progressively increasing risks of graft was seen predominantly in those patients with a one year failure. The relatively large values of RH for the comcreatinine value Յ1.5 (Fig. 4) . Since 1988, there has been bination of these effects indicate the importance of these a gradual decline in mean creatinine values at one year factors together in predicting long-term graft survival.
post-transplantation for all groups. The cumulative disWhen post-transplant renal function was included tribution of one-year serum creatinine has improved in in the model, the RH reduction per year was 1.01 (0.94 1997 compared to 1988 (Fig. 3) . There also has been a to 1.05; P ϭ 0.89). However, if post-transplant renal gradual reduction in acute rejection episodes over time function was excluded, transplants performed in 1993, [2] . However, when renal function within the first year 1996, 1997, and 1998 had reduced RH of graft failure and clinical acute rejection were included in the regrescompared to transplants performed in other years (1988 sion model for long-term graft failure, it was the one to 1992, 1994, and 1995; P Ͻ 0.05). Because the effect year creatinine and ⌬ creatinine values that were signifiof transplant year was no longer significant when postcant, and not the clinical acute rejection episodes (Tatransplant renal function was included in the model, it ble 3). Stratification of cadaveric recipients in this study, is clear that these variables are surrogates for one anaccording to one year creatinine (Յ or Ͼ1.5 mg/dL), other, and improved graft survival rate in recent years ⌬ creatinine (Ͻ0.3 or Ն0.
3) values and clinical acute is due to improved post-transplant renal function during rejection, revealed that renal function is the most importhe same time.
tant predictor of graft survival (Fig. 5) . Thus, in the setting of acute rejection, it is the preservation of renal DISCUSSION function that is more important for graft survival. In previous studies, discharge creatinine was identified The current shortage of organs for transplantation underscores the importance of optimizing long-term graft as a strong predictor of transplant survival [4] . The projected median graft half-life for cadaveric transplants survival. Since1988, there has been a gradual improvement in one-year graft survival. Thus, in recent years with discharge creatinine values of 0.5 to 1.5 mg/dL was 11.5 years. Half-life values for patients with discharge there are more patients with a functioning graft at the end of one year post-transplant. There has also been a serum creatinine 1.6 to 2.5 and Ͼ2.5 mg/dL were 9.6 and 7.2 years, respectively. Discharge creatinine has limited steady improvement in graft half-life [2] . This has occurred despite increasing use of older donors. During value as many patients are discharged within a few days after transplant, before they reach nadir creatinine levels. the period between 1988 and 1997 there also has been a gradual reduction in acute rejection episodes, which is This is true especially for recipients of renal transplants from older donors, those with prolonged cold ischemia an important predictor for late graft failure [2] . Other variables such as recipient and donor age, elevated PRA, time and those who experience DGF. One-month creatinine values may be falsely elevated due to higher cyclopre-transplant dialysis requirements, presence of diabetes and DGF are known to have a detrimental effect on sporine and tacrolimus levels used to prevent acute rejec- tion. Hence, this study used six month and one year creatinine values to predict long-term graft survival. associated with poorer graft survival [10, 11] . First of all, there are known factors that influence long-term outOther investigators using single center studies have noted a strong correlation between serum creatinine at come, such as occurrence of acute rejection, incidence of DGF and HLA mismatching, which have changed favorthree and six months [5] and at one year with longterm survival [6] . Similarly, a ⌬ creatinine of Ͼ0.5 or ably over time. In addition, it is likely that acute rejection episodes have been treated effectively since 1988, thereby Ͼ1.0 mg/dL at six weeks or the pattern of creatinine response after acute rejection have been correlated to preserving renal function and increasing kidney half-life. Treatment and prevention of subclinical acute rejection long-term graft failure [7, 8] . In the current study, all patients transplanted in the US over 11 years were inhas been noted to preserve renal function over time [12] . It is also possible that cyclosporine/tacrolimus nephrocluded in the analysis. This provided an opportunity for a more comprehensive analysis to examine the effects toxicity has diminished over time. Finally, other factors such as optimizing the use of kidneys from older donors of individual variables such as acute rejection episodes, transplant year and post-transplant renal function on [10, 11] , better management of DGF [3, 4, 13] , and better control of hypertension and hyperlipidemia may conlong-term graft survival.
There may be several reasons for the improvement tribute to the preservation of renal function during the first year post-transplantation. The long-term survival imin renal function over time during the first year after transplantation. The improvement has occurred despite provements in recent years appear to be due to enhanced one-year graft survival (Fig. 1) . However, on further careincreasing reliance on older donors, which are generally a Due to the interaction, these terms must be considered in combination to determine all values of the relative hazard function b See illustration of the interaction between 1 year creatinine and ⌬ creatinine in Figure 6 quality of renal function (creatinine Յ1.5 mg/dL at 1 year) should be implemented as a newer endpoint for primary comparative trials.
In conclusion, one year creatinine and ⌬ creatinine values are the variables that correlate best with longterm renal graft survival. Recent improvements in graft half-life for the United States can be attributed to better preservation of renal function within the first year after transplantation. 
